The newly listed stock N Dana on the Beijing Stock Exchange opened more than 440% higher. Dana Bio is mainly engaged in the research, development, production and sales of early serological diagnosis of invasive fungal diseases and in vitro diagnostic products for other pathogenic microorganisms.
